more_reports

INmune Bio Inc.

INMB:NASDAQ

INmune Bio is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease.

streetwise book logo Streetwise Company Fact Sheet

2025/8/4 15:57:36

(INMB:NASDAQ)